Rapt Therapeutics Payables and Accrued Expenses (Quarterly) Insights

Rapt Therapeutics, Inc. (RAPT)

58.02 0.00 (0.00%) USD | NASDAQ | Mar 06, 16:00

View Payables and Accrued Expenses (Quarterly) for RAPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial